Emerging Biosimilars in Therapeutics


Bio similars Market is encountering a development at an exponential rate. By and by around 700 biologics are gaining ground in the exploration pipelines of almost 250 biopharma organizations. Bio similar insulin have just begun changing the future medication improvement in the domain of diabetology. Bio similar of Adalimumab, Etanercept, Rituximab, Peg-Filgrastim, Trastuzumab are required to hit the market soon. Biosimilar of Humatrope, biosimilar of Eprex, biosimilar of Neupogen, biosimilar of Remicade have just been getting a charge out of a more noteworthy piece of the overall industry in Europe than the reference item itself. The extent of various biosimilars that arrived at advertise are Low Molecular Weight Heparins 44%, Epoetins 19%, HGH 11%, G-CSFs 7%, Interferons 6%, Insulins 5%, Others 8%

    Related Conference of Emerging Biosimilars in Therapeutics

    June 19-20, 2023

    5th International Conference on Nucleic Acids

    London, UK
    September 18-19, 2023

    5th International Conference on Biochemistry

    London, UK
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy
    November 01-02, 2023

    19th International Conference on Metabolomics

    Rome, Italy

    Emerging Biosimilars in Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in